跳至主要内容
临床试验/NCT01989702
NCT01989702已完成不适用

The Effect of a Probiotic-based Product on Blood Pressure and Other Known Risk Factors Linked to Cardiovascular Diseases.

Probi AB1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Probi AB
入组人数
142
试验地点
1
主要终点
Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic intervention

研究概览

简要总结

The aim of the present study was to examine the efficacy of a probiotic-based product on either reducing hypertension or preventing a high normal blood pressure from reaching hypertensive levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals at the age of 40-75 years.
  • Blood-pressure >140/90 mmHg that has been confirmed at 2-3 separate occasions or represents the mean value of a 24-hour measurement.
  • Triglycerides >1,7 mmol/L and/or HDL <1 mmol/L (men)/1,29 mmol/L (women).
  • Fasting plasma glucose levels >5,6 mmol/L and/or waist circumference >102 cm (men)/88 cm (women).
  • BMI <40.

排除标准

  • Medically treated allergy or allergy to any of the ingredients of the study product.
  • Medication for high levels of blood lipids.
  • Metabolic disease, such as type one diabetes.
  • Confirmed diseases of the heart, liver of kidneys.
  • Chronic inflammatory disease requiring medication.
  • Pregnant or nursing.
  • Regular intake of other probiotic products (5-7 days per week during the last three months before inclusion into the study).

结局指标

主要结局

Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic intervention

时间窗: Baseline, 3 months

次要结局

  • Changes from baseline of blood parameters, such as inflammatory markers and blood lipids, linked to increased risk for cardiovascular diseases(Baseline, 3 months)

研究者

发起方
Probi AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验